CIK: 1818576 - Address: C/O Revance Therapeutics, Inc., 1222 Demonbreun Street, Suite 2000, Nashville, TN 37203
10 results

TC

Stat

Stk

Ins

Fil

+d

+w

+m

+q

+h

+y

avg

Filing Date

T Date

Ticker

Issuer

Inc

Sector

Ind

Industry

Owner

oSt

Rel

Title

T

TVal

Price

L

Qty

oc

Own

H

r2y

r1y

r6m

r3m

r6w

r3w

r7d

r3d

f1d

f1w

f1m

f3m

f6m

f1y
8/17/21 18:20
8/16/21
RVNCRevance Therapeutics, Inc.DEHealthDrugPharmaceutical PreparationsRankin AubreyTNDOP,InnovaS-24726.340-9-2541D
7/30/21 20:57
7/28/21
RVNCRevance Therapeutics, Inc.DEHealthDrugPharmaceutical PreparationsRankin AubreyTNDOP,InnovaS-1,63330.060-54-9556I
7/28/21 21:48
7/26/21
RVNCRevance Therapeutics, Inc.DEHealthDrugPharmaceutical PreparationsRankin AubreyTNDOP,InnovaS-1,64629.720-55-8610I
4/6/21 19:41
4/5/21
RVNCRevance Therapeutics, Inc.DEHealthDrugPharmaceutical PreparationsRankin AubreyTNDOP,InnovaS028.28000665I
3/5/21 20:10
3/4/21
RVNCRevance Therapeutics, Inc.DEHealthDrugPharmaceutical PreparationsRankin AubreyTNDOP,InnovaS-84225.430-33-5665I
2/3/21 20:13
2/1/21
RVNCRevance Therapeutics, Inc.DEHealthDrugPharmaceutical PreparationsRankin AubreyTNDOP,InnovaS-85925.950-33-5687I
1/4/21 20:01
12/30/20
RVNCRevance Therapeutics, Inc.DEHealthDrugPharmaceutical PreparationsRankin AubreyTNDOP,InnovaS-92127.820-33-4720I
12/2/20 20:55
11/30/20
RVNCRevance Therapeutics, Inc.DEHealthDrugPharmaceutical PreparationsRankin AubreyCADOP,InnovaS-79023.850-33-4753I
10/30/20 20:24
10/29/20
RVNCRevance Therapeutics, Inc.DEHealthDrugPharmaceutical PreparationsRankin AubreyCADOP,InnovaS-86626.150-33-4786I
9/30/20 21:21
9/28/20
RVNCRevance Therapeutics, Inc.DEHealthDrugPharmaceutical PreparationsRankin AubreyCADOP,InnovaS-86726.180-33-4819I

DDerivative transaction in filing (usually option exercise)
MMultiple transactions in filing; earliest reported transaction date and weighted average transaction price
AAmended filing
EError detected in filing
S - SaleSale of securities on an exchange or to another person
S - Sale+OESale of securities on an exchange or to another person (after option exercise)
F - TaxPayment of exercise price or tax liability using portion of securities received from the company
P - PurchasePurchase of securities on an exchange or from another person
Return to top

Contact